Skip to main content
Premium Trial:

Request an Annual Quote

Indee Labs, GenScript Partner to Develop DNA Knock-In Tech

NEW YORK — Indee Labs said on Thursday that it has signed an agreement to use its Hydropore non-viral intracellular delivery technology to develop a DNA knock-in kit in collaboration with GenScript.

According to Berkeley, California-based Indee, Hydropore uses microfluidic vortex shedding to rapidly deliver nucleic acids, proteins, and gene-editing complexes into immune cells. Under the terms of their deal, Indee will optimize the technology for use with a variety of single-strand and double-strand constructs provided by GenScript.

Indee said that it will evaluate functional differences between T cells processed with Hydropore and electroporation as part of the alliance and that the companies aim to develop and comarket a DNA knock-in kit that can be used for large transgene inserts for non-viral CRISPR gene editing in immune and other cells.

"We expect the Hydropore system will provide our gene and cell therapy customers with an efficient method of non-viral gene editing using our GenCRISPR sgRNA and ss/dsDNA HDR templates," Ray Chen, president of GenScript's life sciences group, said in a statement.

In September, Piscataway, New Jersey-based GenScript partnered with Avectas to develop a non-viral cell therapy manufacturing process for the delivery of gene editing constructs.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.